An Intervention Study Evaluating the Effects of a Raspberry Leaf Extract in an Osteoarthritic Population.

NCT03703024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2019-01-10

No results posted yet for this study

Summary

A double-blind, randomized, placebo-controlled clinical study to evaluate the efficacy of raspberry extract to alleviate symptoms of osteoarthritis in the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

DIETARY_SUPPLEMENT

Raspberry Leaf Extract

Eligible subjects will be scheduled for an initial visit. The study will involve 3 visits over a 12 to 13-week period. One capsule to be taken every morning over a 12-13 week period.

DIETARY_SUPPLEMENT

Placebo

Delivered in a capsule

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    lead INDUSTRY

Principal Investigators

  • Prof Michael Molloy · Consultant Rheumatologist, Consultants Private Clinic, Cork University Hospital, Bishopstown road, Wilton, Cork.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03703024 on ClinicalTrials.gov